Burning Rock Biotech annual depreciation and amortization
2020
2021
2022
2023
2024
2025
Burning Rock Biotech Depreciation & Amortization Growth & History (BNR)
Burning Rock Biotech's depreciation and amortization was $3.1M for fiscal 2025.
View full Burning Rock Biotech company overviewBurning Rock Biotech annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $3.1M | −$4.0M | −56.48% |
| 2024 | 2024-12-31 | $7.2M | −$11.6M | −61.94% |
| 2023 | 2023-12-31 | $18.8M | $797,000 | +4.43% |
| 2022 | 2022-12-31 | $18.0M | $10.5M | +140.02% |
| 2021 | 2021-12-31 | $7.5M | $2.4M | +46.84% |
| 2020 | 2020-12-31 | $5.1M | — | — |
Burning Rock Biotech depreciation and amortization trends
Over the last five fiscal years, Burning Rock Biotech's depreciation and amortization decreased from $5.1M to $3.1M, a change of −$2.0M.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Burning Rock Biotech source filings ↗